HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Maybelline sales growth revived by Revitalizing line in second quarter.

This article was originally published in The Rose Sheet

Executive Summary

MAYBELLINE REVITALIZING SALES JUMP 54% for the year through June 17 based on A.C. Nielsen data, Maybelline announced in a July 19 release reporting the company's sales and earnings results for the second quarter and first half (ended June 30). The first-half performance of the Revitalizing line represents a turnaround for the brand and for Maybelline as well -- "slower-than-planned" rollout of the product line held back Maybelline sales growth in the third and fourth quarters of last year ("The Rose Sheet" Jan. 30, p. 12)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel